Skip to content

The Impact of Ultrasound-Guided Stellate Ganglion Block Based on Infrared Thermography on the Quality of Postoperative Recovery Following Uvulopalatopharyngoplasty

The Impact of Ultrasound-Guided Stellate Ganglion Block Based on Infrared Thermography on the Quality of Postoperative Recovery Following Uvulopalatopharyngoplasty

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500113052
Enrollment
Unknown
Registered
2025-11-24
Start date
2025-11-24
Completion date
Unknown
Last updated
2025-12-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Uvulopalatopharyngoplasty

Interventions

Sponsors

Xuzhou Mining Group General Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1. Patients scheduled to undergo uvulopalatopharyngoplasty under general anesthesia between 8:00 AM and 12:00 PM; 2. Age 28-57 years old; 3. ASA I-III grade; 4. Informed consent was obtained from the patient.

Exclusion criteria

Exclusion criteria: 1. BMI > 35kg/m^2 or < 18kg/m^2; 2. Pregnant and lactating women; 3. Patients who were allergic to the study drugs; 4. Patients with severe cardiopulmonary dysfunction, severe liver and kidney dysfunction, and previous pain syndrome; 5. Patients with opioid dependence and long-term use of analgesics; 6. Patients with contraindications to stellate ganglion block; 7. Patients with severe mental illness, unable to communicate; 8. Coagulation dysfunction or use of anticoagulant drugs; 9. Patients enrolled in other trials.

Design outcomes

Primary

MeasureTime frame
Qor-40 scale scores at 24 hours postoperatively;

Secondary

MeasureTime frame
Visual analogue scale (VAS);Postoperative adverse reactions (nausea, vomiting, snoring);Pittsburgh Sleep quality Index scale;

Countries

China

Contacts

Public ContactMingjian Kong

Xuzhou Mining Group General Hospital

17751991669@126.com+86 177 5199 1669

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026